A 52-year-old woman with a seven-year history of rheumatoid arthritis (RA) was transferred to our department with chronic renal failure to undergo hemodialysis. She had been treated with prednisolone for a long time, and had renal amyloidosis secondary to RA. During her hospitalization, a left pleural effusion developed. Pleural fluid cultured positive for Cryptococcus neoformans (CN), and the CN antigen was detected in both pleural fluid and serum. Chest computerized tomography revealed an infiltrate shadow in the left lower lung field suggestive of CN infection. This wassuccessfully treated with anti-fungal agents. Pleural effusion is an unusual manifestation of pulmonary cryptococcosis.
Introduction
Cryptococcal pulmonary infection rarely occurs in healthy or compromised persons (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) .
Cryptococcus neoformans (CN) infection associated with pleural effusion is uncommon, even in patients with acquired immunodeficiency syndrome (AIDS) (4, (6) (7) (8) (9) (10) . Here, wereport a rare case ofpleural effusion due to CN that developed in a patient with chronic renal failure receiving long-term corticosteroid treatment for rheumatoid arthritis (RA).
Case Report
A 52-year-old womanwas transferred to our department on December 3, 1996 to receive hemodialysis treatment for chronic renal failure. She had been treated with prednisolone (PSL) (maintenance dose of 10 mg/day) for rheumatoid arthritis (RA) since she was 45 years old. At 50 years of age, she had undergone a left nephrectomy due to renal cell carcinoma, and was diagnosed with renal amyloidosis.
Since then, non-steroidal On admission, her serum creatinine (Cr) level was 4.4 mg/dl, and she had gained 10 kg in weight. Chest roentgenograms revealed pulmonary congestion and bilateral pleural effusion. She underwent hemodialysis twice weekly from December 5, and thereafter the bilateral pleural effusion resolved and her general condition improved. However, ileus occurred in midJanuary 1997, and a loop colostomy was carried out on January 23 in the Department of Surgery. Later, her ileus proved to be paralytic due to intestinal amyloidosis.
After surgery, disseminated intravascular coagulation (DIC) occurred which was triggered by postoperative infection, and she was transferred back to our ward on January 29.
On the same day (1/29), laboratory data (Table 1) showed thrombocytopenia (3.5x104/|jl), enhanced coagulation activity, and raised C-reactive protein (CRP) (15.7 mg/dl). Following treatment with antibiotics and gabexate mesilate (FOY), her platelet counts and CRP returned to normal levels, 40.2xl04/|nl and0.3 mg/dl, respectively (2/10). However, her fever returned on February 1 1 and her CRP was elevated to 9.9 mg/dl on the Feb. 17. Chest roentogenograms (2/17) ( Fig. 1) revealed a left pleural effusion. The next day, thoracentesis was carried out and Cryptococcus neoformans was cultured ( Table 2 ). The CN antigen was also detected in both pleural fluid and serum. No signs of meningitis were observed. Chest computerized tomography (CT) (Fig. 2) Pleural Effusion due to C. neoformans Pleural effusion due to RA also appeared to be unlikely, because the activity ofRA was stable clinically and the level of glucose in the effusion was not low (110 mg/dl).
Anti-fungal therapy was begun on Feb. 21 (Fig. 3) . She was first treated with amphotericin B (AMPH) Figure 2 . Chest CT scan (3/7) revealed a parenchymal infiltrate shadow in the left lower lung field suggestive of CN infection and a left pleural effusion.
intravenously (div), and then intrapleurally (ipl). Culture of pleural fluid for CN became negative (2/28), CN antigen titer decreased from 1:64 (3/3) to 1: 16 (4/14) (Table 3) , and the left pleural effusion and parenchymal shadow were resolved by the end of May. Since the serum CN antigen remained positive, flucytosine (5-FC) and fluconazole (FCZ) were continued orally. She was discharged from the hospital on June 18, and has since been treated with PSL at a daily dose of 5 mg, FCZ at 100 mg and 5-FC at 2 g twice weekly following hemodialysis at the outpatient clinic.
Discussion
Cryptococcus neoformans infection rarely occurs in healthy or compromised persons. As for pulmonary manifestations of CN infection, parenchymal nodules are common in the case of healthy persons. Conversely, diffuse interstitial infiltrates, alveolar consolidation, ground glass shadow, and mediastinal or hilar lymphadenopathy are most commonly seen in cases of compromised persons with a disease such as AIDS (4, (6) (7) (8) (9) (10) . In the present case, a localized interstitial infiltrate shadow was observed on the chest CT (Fig. 2) , but was not considered typical of CN infection, probably due to the fact that our case was not an AIDS patient.
Among the parenchymal, nodular, and pleural abnormalities, pleural abnormality is reported to be the most uncommon pulmonary manifestation of CN infection. The frequencies of patients with pleural effusion due to CN infection are reported for such cases. The present case had also undergone treatment with PSL over a long period, and her chronic renal failure itself may also have been immunosuppressive. The characteristic of pleural effusion in our case was exudate and lymphocyte predominancy, and these findings were in agreement with the reports of several investigators (3, 6) . According to the review literature (3), positive rates for cryptococci in pleural fluid are not so high; only ll out of 26 cases were shown to be positive. Salyer and Sayler (2) reported that negative cultures might be due to the fact that the effusion results not from the growth of organisms, but rather from the release of antigen into the pleural fluid, just as occurs in M. tuberculosis. In fact, they had identified subpleural nodule as a part of the primary pulmonary lymph nodal complex in 6 out of 7 autopsy cases with pleural cryptococcosis. In the present case, the effusion seemed to result from the growth of the organism i n the pleural cavity.
The cryptococcal antigen was positive in both the fluid and serum in our case. The cryptococcal antigen test is reported to be a useful adjunct in confirming a diagnosis and in assessing the response to treatments (3). Diamond and Bennett (12) showed that patients with cryptococcal meningitis who had relapsed had persistently high posttreatment titers ofcryptococcus antigen in their serum or cerebrospinal fluid. They warned that there is a high possibility of relapse in patients who continue to receive daily corticosteroid therapy at doses of over 20 mg of PSL after undergoing antifungal therapy. The cryptococcal antigen in the serum is still positive in our case, so we will continue to administer antifungal drugs orally for a certain period.
Although cryptococcal pleural effusion is uncommon, this disease should be considered in patients who have serious underlying diseases, especially when they have been receiving corticosteroid for a long period of time. We think it is important to include the cryptococcal antigen test or culture in the evaluation of pleural effusion in such patients.
